Compare VZLA & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VZLA | AORT |
|---|---|---|
| Founded | 2017 | 1984 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 975.7M |
| IPO Year | 2019 | 1996 |
| Metric | VZLA | AORT |
|---|---|---|
| Price | $3.54 | $21.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $7.00 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 6.5M | 734.4K |
| Earning Date | 12-12-2025 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | N/A | $11.20 |
| P/E Ratio | ★ N/A | $706.33 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $2.82 | $19.16 |
| 52 Week High | $7.19 | $48.25 |
| Indicator | VZLA | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 36.93 |
| Support Level | $3.15 | $19.49 |
| Resistance Level | $3.61 | $24.70 |
| Average True Range (ATR) | 0.24 | 0.99 |
| MACD | -0.01 | 0.54 |
| Stochastic Oscillator | 37.63 | 48.75 |
Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.